WANG Lu-ming, ZHANG Wen-lan, LYU Nuan, et al. Research Advance of Chinese Medicine in Treating Atherosclerosis: Focus on Lipoprotein-Associated Phospholipase A2. [J]. Chinese Journal of Integrative Medicine 30(3):277-288(2024)
DOI:
WANG Lu-ming, ZHANG Wen-lan, LYU Nuan, et al. Research Advance of Chinese Medicine in Treating Atherosclerosis: Focus on Lipoprotein-Associated Phospholipase A2. [J]. Chinese Journal of Integrative Medicine 30(3):277-288(2024) DOI: 10.1007/s11655-023-3611-6.
Research Advance of Chinese Medicine in Treating Atherosclerosis: Focus on Lipoprotein-Associated Phospholipase A2
atherosclerosis (AS) causes chronic inflammation and oxidative stress in the body and poses a threat to human health. Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a member of the phospholipase A2 (PLA2) family
and its elevated levels have been shown to contribute to AS. Lp-PLA2 is closely related to a variety of lipoproteins
and its role in promoting inflammatory responses and oxidative stress in AS is mainly achieved by hydrolyzing oxidized phosphatidylcholine (oxPC) to produce lysophosphatidylcholine (lysoPC). Moreover
macrophage apoptosis within plaque is promoted by localized Lp-PLA2 which also promotes plaque instability. This paper reviews those researches of Chinese medicine in treating AS via reducing Lp-PLA2 levels to guide future experimental studies and clinical applications related to AS.
关键词
脂蛋白磷脂酶A2动脉粥样硬化炎症氧化应激细胞凋亡中医药治疗
Keywords
lipoprotein-associated phospholipase A2atherosclerosisinflammationoxidative stressapoptosisChinese medicine